Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Bruker Announces Acquisition of Prairie Technologies

Published: Friday, September 13, 2013
Last Updated: Thursday, September 12, 2013
Bookmark and Share
Acquisition strengthens Bruker Nano Surfaces Division's position in life science markets.

Bruker Corporation has announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products.

The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.

Headquartered near Madison, Wisconsin, privately-held Prairie pioneered the use of multiphoton fluorescence microscopy. Its industry-leading multiphoton product offerings have enabled researchers to make revolutionary discoveries in neurobiology and cell biology.

Prairie's products serve an addressable market that is estimated to be more than $150 million annually. The addition of Prairie will enable Bruker to enter the fluorescence microscopy market, which consists of multipoint scanning confocal, single-photon confocal, and multiphoton products.

Prairie has approximately 30 employees globally, and generated revenues of approximately $11 million in 2012. Bruker intends to operate Prairie Technologies as a business unit in the Madison, Wisconsin area, and plans to leverage the global marketing, distribution and service capabilities of the Bruker Nano Surfaces division.

"Prairie Technologies led the way in developing the multiphoton fluorescence microscopy field. Their products and innovations are impressive and have created an enthusiastic following of customers who have used their instruments to achieve groundbreaking results," said Mark R. Munch, Ph.D., President of the Bruker MAT Group.

Munch continued, "Their Ultima two-photon microscopy product line and the new Opterra swept field multipoint scanning confocal fluorescence product line present new exciting areas of growth for Bruker, while providing significant synergies with our Bio-AFM offerings."

"For over seventeen years, Prairie Technologies has been committed to providing leading optical instrument designs and rich software features to researchers in neurobiology and cell biology," remarked Mike Szulczewski, Founder and President of Prairie Technologies, Inc.

Szulczewski continued, "We are extremely pleased to join Bruker, and look forward to continued innovation in the Bruker environment, as well as to enhanced global distribution and service capabilities for our customers."

Scientists conducting uncaging experiments, optogenetics, simultaneous electrophysiology studies, as well as photoactivation, photostimulation and photoablation experiments use Prairie Technologies' systems.

The suite of product solutions for neurobiologists and cell biologists include the Ultima and Ultima In-Vivo two-photon microscopy product lines.

These platforms and the many associated accessories and flexible configurations enable advanced brain slice and intra-vital studies deep into tissues to over 900 microns in penetration depth.

In addition, the new Opterra swept field multipoint scanning confocal fluorescence microscope enables high-speed, live cell imaging and unsurpassed dynamic observation of fast cellular events.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Bruker’s NMR FoodScreener™ Laboratory Achieves ISO/IEC 17025 Accreditation
Bruker announced that its NMR FoodScreener™ laboratory for food authenticity and quality determination, located in Rheinstetten, Germany, has been granted ISO/IEC 17025 accreditation.
Monday, September 28, 2015
Full Range of Bruker Systems Installed in New Pre-Clinical Imaging Laboratory
Researchers, clinicians, health educators and policy makers all gathered as the new Multidisciplinary Centre for Research into Obesity and Related Comorbidities (Cepid-OCRC) was opened at da Universidade Estadual de Campinas (UNICAMP).
Thursday, June 18, 2015
UK National Graphene Institute Selects Bruker as Official Partner
World-leading graphene research facility purchases multiple Bruker AFMs.
Tuesday, April 07, 2015
PREMIER Biosoft Announces Reseller Agreement with Bruker
Agreement aims to advance lipidomics and metabolomics research.
Monday, November 17, 2014
Bruker Sells GC Business
Bruker completed the divestiture of its GC and GC single-quadrupole (GC-SQ) mass spectrometry products to Techcomp Europe Ltd on October 31st.
Tuesday, November 04, 2014
Bruker Awarded Fourth PeakForce Tapping Patent
AFM mode uniquely combines highest resolution imaging and material property mapping.
Thursday, July 24, 2014
Using LC-MS to Analyse Sulfonamides in Food Grade Honey
Sulfonamides are one of a number of groups of chemicals whose presence in honey is limited by international regulations.
Tuesday, July 22, 2014
Bruker MALDI Biotyper™ Receives CFDA Clearance
Company receives clearance from the China Food and Drug Administration to market and sell its IVD MALDI Biotyper System as a medical device in China for the identification of microorganisms isolated from human specimens.
Thursday, June 26, 2014
Bruker Reports 7% Revenue Growth in Q4
Bruker Corporation reported financial results for its fourth quarter and full year ended December 31, 2013.
Wednesday, February 19, 2014
Bruker Opens New Preclinical Imaging Center of Excellence for the Americas
Massachusetts Center will provide advanced development, demonstration and customer support capabilities for Bracer’s unique multimodal preclinical imaging systems portfolio.
Thursday, January 30, 2014
Bruker Corporation Appoints Dr. Gilles Martin to its Board of Directors
Dr. Martin is Chairman and Chief Executive Officer of the Eurofins Scientific Group.
Monday, January 20, 2014
World’s First Compact 900 MHz Actively Refrigerated Magnet for NMR Installed at UCSD
Bruker announce the successful installation of an Ascend™ Aeon 900 magnet, the world’s first compact, single-story NMR magnet with active refrigeration.
Wednesday, December 11, 2013
Bruker Granted FDA Clearance to Market the MALDI Biotyper CA System
Bruker able to market MALDI Biotyper CA System in the US for the identification of Gram negative bacterial colonies cultured from human specimens.
Tuesday, November 26, 2013
Bruker and SISCAPA Assay Technologies Announce Second-Phase Collaboration Agreement
The ongoing collaboration aims to exploit MALDI-TOF instruments as an alternative to nano-LC-MS technology currently used in many SISCAPA assays.
Monday, September 16, 2013
Novel Approach for Inborn Errors of Metabolism Screening by NMR
Clinical IEM-by-NMR screening study in Turkey measures 65 metabolites in urine simultaneously, including 20 endogeneous metabolites and 45 metabolites associated with inborn errors of metabolism.
Wednesday, September 04, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Revolutionary Technologies Developed to Improve Outcomes for Lung Cancer Patients
Breath test to detect lung cancer brings oxygen directly to the wound.
NIH Supports New Studies to Find Alzheimer’s Biomarkers in Down Syndrome
Initiative will track dementia onset, progress in Down syndrome volunteers.
Dementia Linked to Deficient DNA Repair
Mutant forms of breast cancer factor 1 (BRCA1) are associated with breast and ovarian cancers but according to new findings, in the brain the normal BRCA1 gene product may also be linked to Alzheimer’s disease.
Using Drug-Susceptible Parasites to Fight Drug Resistance
Researchers at the University of Georgia have developed a model for evaluating a potential new strategy in the fight against drug-resistant diseases.
Boosting Breast Cancer Treatment
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
New Gene Map Reveals Cancer’s Achilles’ Heel
Team of researchers switches off almost 18,000 genes
New Discovery Sheds Light on Disease Risk
Gaps between genes interact to influence the risk of acquiring disease.
How Cells ‘Climb’ to Build Fruit Fly Tracheas
Mipp1 protein helps cells sprout “fingers” for gripping.
Research Finding Could Lead to Targeted Therapies for IBD
Findings published online in Cell Reports.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos